2
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Laboratory Notes

Erythroblastosis Fetalis in Twins: Two Unusual Cases

, M.D., , M.D., , M.D. & , M.D.
Pages A-38-A-47 | Published online: 18 Apr 2016

REFERENCES

  • Levine, P., Robinson, E., Stroup, M., McGee, R. and Bushnell, L. N.: A summary of atypical antibodies, rare genotypes and ABO hemolytic disease encountered in a one-year survey. Blood 11:1097–1117, 1956.
  • Mollison, P. L.: Blood Transfusion in Clinical Medicine. Ed. 3. Oxford, England, Blackwell, 1958, p. 324.
  • Nappi, R.: Eritroblastosi fetale da isosensibilizzazione verso il fattore rh”. Arch ostet. e ginec. 64: 402–405, 1959.
  • Ebaugh, F. G., Jr., Emerson, F. D. and Ross, J. F.: Use of radioactive chromium51 as an erythrocyte tagging agent for the determination of red cell survival in vivo. J. Clin. Invest. 32:1260, 1953.
  • Van Loghem, J. J., Bakx, C. J. A. and Klomp-Macnee, W.: Haemolytic disease of the newborn due to iso-immunization by the antigens c and Cw. Vox sang, (o.s.) 3:130–132, 1953.
  • Hyatt, H. W., Sr.: Hemolytic disease of the newborn in a pair of monozygotic twins due to sensitization to blood factor hr'. Exper. Med. & Surg. 17:262–271, 1959.
  • Race, R. R. and Sanger, R.: Blood Groups in Man. Ed. 3. Oxford, England, Blackwell, 1959, p. 132.
  • Krivit, W.: The use of radioactive chromium in hemolytic anemias. Thesis, University of Minnesota Graduate School, Minneapolis, 1958.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.